<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04955288</url>
  </required_header>
  <id_info>
    <org_study_id>2021-0420</org_study_id>
    <nct_id>NCT04955288</nct_id>
  </id_info>
  <brief_title>Research on Key Technologies and System Optimization of Early Warning and Resuscitation of Cardiac Arrest</brief_title>
  <official_title>Research on Key Technologies and System Optimization of Early Warning and Resuscitation of Cardiac Arrest</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Affiliated Hospital, School of Medicine, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Second Affiliated Hospital, School of Medicine, Zhejiang University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Studies have shown that early prevention and warning of cardiac arrest, rapid implementation&#xD;
      of high-quality cardiopulmonary resuscitation, and strengthening of organ function protection&#xD;
      after resuscitation are the keys to reducing the occurrence of cardiac arrest and improving&#xD;
      the prognosis of patients. However, there are still many problems in the field of&#xD;
      cardiopulmonary resuscitation in my country: 1) lack of effective prevention and early&#xD;
      self-rescue system for cardiac arrest; 2) traditional resuscitation techniques implemented in&#xD;
      pre-hospital and emergency rooms and poor results; 3) organs after resuscitation Insufficient&#xD;
      protection means and effects. In our early stage, focusing on the above key issues, the study&#xD;
      found that 5G technology can help high-risk emergency events including early warning, early&#xD;
      detection and first aid of cardiac arrest. Aortic balloon occlusion can significantly improve&#xD;
      the effectiveness of cardiopulmonary resuscitation. Transesophageal and CRRT cooling Can&#xD;
      significantly optimize the organ protection intensity of therapeutic hypothermia. On the&#xD;
      basis of the preliminary work, this project will carry out the research and development and&#xD;
      clinical application of a series of new technologies for cardiac arrest warning and&#xD;
      resuscitation, and work hard to help with cardiac arrest. Early warning and treatment of&#xD;
      cases provide a set of optimized diagnosis and treatment technical solutions, which has&#xD;
      important scientific, clinical and social significance.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. During the period from January 2022 to December 2023, based on the early warning and&#xD;
           emergency response system of cardiac arrest, real-time monitoring of the vital&#xD;
           information of the recruited high-risk populations of cardiac arrest, and timely&#xD;
           reporting of the above-mentioned populations with unstable vital signs Distribute early&#xD;
           warning information, contact community doctors to provide medical assistance, 120&#xD;
           emergency centers for referrals, and hospitals to prepare for admission, etc., in order&#xD;
           to reduce the occurrence of cardiac arrest in high-risk groups; ②January 2022-December&#xD;
           2023 During the period, when a cardiac arrest event occurred in the recruited population&#xD;
           based on the above-mentioned system, the nearby social volunteers, community doctors,&#xD;
           and 120 emergency centers were quickly activated. Rescue team members quickly went to&#xD;
           rescue, and at the same time realized experts' real-time observation and guidance of&#xD;
           on-site treatment scenes through the remote consultation system, and prepared for&#xD;
           continuous treatment in the hospital, in order to improve the effect of resuscitation&#xD;
           and treatment of cardiac arrest in high-risk populations; ③analyze the above Within 2&#xD;
           years of application of the system, the incidence of cardiac arrest and the outcome of&#xD;
           early resuscitation and treatment in the recruited high-risk population.&#xD;
&#xD;
        2. Selected patients with cardiac arrest in our hospital from January 2022 to December&#xD;
           2023. Selection criteria: a. 18-75 years old, no gender limit; b. Advanced life support;&#xD;
           c. Meet ethical requirements and sign informed consent. Exclusion criteria: a. Refusal&#xD;
           of cardiopulmonary resuscitation; b. Indications of non-resuscitation for traumatic&#xD;
           cardiac arrest; c. Patients with terminal malignant tumors or other diseases. The&#xD;
           patients undergoing cardiac arrest were randomly divided into the traditional&#xD;
           cardiopulmonary resuscitation group and the aortic balloon-assisted resuscitation group.&#xD;
           The former adopts the traditional chest compression mode, and the latter uses aortic&#xD;
           balloon blockade on the basis of the traditional resuscitation mode. Technology, compare&#xD;
           the resuscitation effects of patients with cardiac arrest in our hospital within 2&#xD;
           years, such as the duration of cardiopulmonary resuscitation, the amount of adrenaline,&#xD;
           the number of defibrillation, the success rate of resuscitation, the survival rate of&#xD;
           admission, etc., to clarify that aortic balloon occlusion can improve the effectiveness&#xD;
           of cardiopulmonary resuscitation Significant role in.&#xD;
&#xD;
        3. Selected patients with cardiac arrest in our hospital from January 2022 to December&#xD;
           2023. Selection criteria: a. 18 to 75 years old, no gender limit; b. return to&#xD;
           spontaneous circulation; c. coma; d. meet ethical requirements and sign informed&#xD;
           consent. Exclusion criteria: a. Cardiac arrest time&gt; 10 min; b. Cardiopulmonary&#xD;
           resuscitation time&gt; 60 min; c. Hemodynamics need to be maintained by high-dose&#xD;
           vasoactive drugs (adrenaline or norepinephrine dosage&gt; 1μg/kg.min); d. The state of&#xD;
           dying; e. Patients with advanced malignant tumors or other end-stage diseases. Cardiac&#xD;
           arrest patients who had obtained spontaneous circulation were randomly divided into&#xD;
           traditional cooling group and esophageal cooling group, respectively, as soon as&#xD;
           possible after resuscitation, using body surface cooling blanket device and esophageal&#xD;
           cooling device to implement sub-hypothermia, and compare the effect of low-temperature&#xD;
           implementation in patients within 2 years, such as the start time, Target length,&#xD;
           maintenance of low temperature, rewarming and other indicators, as well as clinical&#xD;
           prognostic indicators such as multiple organ dysfunction, adverse events, ICU length of&#xD;
           stay, total length of stay, immediate discharge and neurological prognosis and survival&#xD;
           at 1, 3, and 6 months In order to clarify the strong protective effect of optimal&#xD;
           implementation of therapeutic mild hypothermia through the esophagus on multiple organ&#xD;
           damage after resuscitation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">November 30, 2024</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>return of spontaneous circulation (ROSC)</measure>
    <time_frame>1-3 hours</time_frame>
    <description>ROSC can be identified with the following three conditions: 1. arterial pulse can be reached; 2. effective ECG rhythm; 3. systolic blood pressure &gt; 60 mmHg (1 mm Hg = 0.133 kPa).</description>
  </primary_outcome>
  <other_outcome>
    <measure>survival to discharge</measure>
    <time_frame>2 days</time_frame>
    <description>whether patients survive to hospital discharge</description>
  </other_outcome>
  <other_outcome>
    <measure>survival to discharge without severe neurological impairment</measure>
    <time_frame>2 days</time_frame>
    <description>defined as a CPC score of 1~2, which denotes survival with no more than moderate neurological disability with the ability to walk without assistance.</description>
  </other_outcome>
  <other_outcome>
    <measure>1-month survival without severe neurological impairment</measure>
    <time_frame>1 months</time_frame>
    <description>patients who have survived for 1 month after cardiac arrest with a CPC score of 1~2</description>
  </other_outcome>
  <other_outcome>
    <measure>6-month survival without severe neurological impairment</measure>
    <time_frame>6 months</time_frame>
    <description>patients who have survived for 6 months after cardiac arrest with a CPC score of 1~2</description>
  </other_outcome>
  <other_outcome>
    <measure>insertion-related complications</measure>
    <time_frame>2 days</time_frame>
    <description>Whether esophageal mucosal injury,aortic injury,or some other complications occur in patients</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Emergencies</condition>
  <arm_group>
    <arm_group_label>Aortic balloon Assisted resuscitation group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The aortic balloon-assisted resuscitation group uses aortic balloon occlusion technology on the basis of the traditional resuscitation mode, that is, when the cardiopulmonary resuscitation begins, the aortic balloon catheter is quickly punctured and inserted to the distal end of the aortic area I via ultrasound. (Septum level), then continue to inflate the balloon to block the aortic blood flow until the end of the cardiopulmonary resuscitation to deflate the balloon and remove the balloon catheter.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Traditional cardiopulmonary resuscitation group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The traditional cardiopulmonary resuscitation group uses the traditional manual chest compression mode, that is, referring to the latest version of the cardiopulmonary resuscitation guidelines, manual chest compressions are performed under the monitoring of the compression quality feedback device to ensure that the compression depth is 5-6cm, the frequency is 100-120 times/min, Conditions such as a fixed compression position and sufficient chest wall rebound.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Esophageal cooling group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The esophageal cooling group adopts a new transesophageal cooling method, that is, an esophageal cooling catheter is placed after resuscitation in patients with cardiac arrest, and then a small temperature-controlled water circulation system is continuously perfused with 4℃ cold water. After the patient's body temperature reaches the target temperature of 33℃, the temperature is adjusted Control the water circulation system to maintain the target body temperature of (33±0.5)°C for 24 hours, and then reheat to (37±0.5)°C normal body temperature at a rate of 0.25-0.5°C/h and maintain it for 24 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Traditional cooling group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The traditional cooling group uses the traditional body surface ice blanket cooling method, that is, the patients with cardiac arrest lie on the temperature control blanket after resuscitation, and then use the ice blanket host to continuously infuse the temperature control blanket with 4℃ cold water, and wait until the patient's body temperature reaches the target temperature of 33℃ After that, adjust the ice blanket host to control the circulating water temperature to maintain the target body temperature of (33±0.5)°C for 24 hours, and then reheat to the normal body temperature of (37±0.5)°C at a rate of 0.25-0.5°C/h and maintain it for 24 hours.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Aortic balloon assisted resuscitation</intervention_name>
    <description>On the basis of the traditional resuscitation mode, the aortic balloon occlusion technology is used, that is, at the same time when the cardiopulmonary resuscitation starts, the aortic balloon catheter is quickly punctured to the distal end of the aortic zone I (septum level) through ultrasound assistance, and then Continue to inflate the balloon to block the aortic blood flow until the end of the cardiopulmonary resuscitation to deflate the balloon and remove the balloon catheter.</description>
    <arm_group_label>Aortic balloon Assisted resuscitation group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Traditional cardiopulmonary resuscitation</intervention_name>
    <description>Use the traditional manual chest compression mode, that is, refer to the latest version of the CPR Guidelines.&#xD;
Artificial chest compressions are performed under the monitoring of the pressure quality feedback device to ensure that the compression depth is 5-6cm, the frequency is 100-120 times/min, the compression position is fixed, and the chest wall fully rebounds.</description>
    <arm_group_label>Traditional cardiopulmonary resuscitation group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Esophageal cooling</intervention_name>
    <description>The new transesophageal cooling method is adopted, that is, the esophageal cooling catheter is indwelled after resuscitation in patients with cardiac arrest, and then connected to a small temperature-controlled water circulation system to continuously infuse 4℃ cold water. After the patient's body temperature reaches the target temperature of 33℃, the temperature-controlled water circulation system is adjusted Maintain the target body temperature of (33±0.5)°C for 24 hours, and then rewarm to (37±0.5)°C normal body temperature at a rate of 0.25-0.5°C/h and maintain it for 24 hours.</description>
    <arm_group_label>Esophageal cooling group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>traditional cooling</intervention_name>
    <description>The traditional body surface ice blanket cooling method is adopted, that is, the patient with cardiac arrest lies on the temperature control blanket after resuscitation, and then uses the ice blanket host to continuously infuse the temperature control blanket with 4℃ cold water, and wait until the patient's body temperature reaches the target temperature of 33℃. The temperature of the circulating water is controlled by adjusting the ice blanket host to maintain the target body temperature of (33±0.5)°C for 24 hours, and then reheat to the normal body temperature of (37±0.5)°C at a rate of 0.25-0.5°C/h and maintain it for 24 hours.</description>
    <arm_group_label>Traditional cooling group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        18-75 years old Provide advanced life support Meet ethical requirements and sign informed&#xD;
        consent return to spontaneous circulation coma&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Refusal of cardiopulmonary resuscitation Indications of non-resuscitation in the presence&#xD;
        of traumatic cardiac arrest Patients with terminal malignant tumors or other diseases&#xD;
        Cardiac arrest time&gt;10min Cardiopulmonary resuscitation time&gt;60min Hemodynamics need to be&#xD;
        maintained by large doses of vasoactive drugs (adrenaline or norepinephrine&#xD;
        dosage&gt;1μg/kg.min) On the verge of Death status Patients with advanced malignant tumors or&#xD;
        other end-stage diseases&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mao Zhang, PHD</last_name>
    <role>Study Chair</role>
    <affiliation>Second Affiliated Hospital of Zhejiang University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mao Zhang, PHD</last_name>
    <phone>86-571-87784654</phone>
    <email>z2jzk@zju.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Second Affiliated Hospital, Zhejiang University School of Medicine &amp; Institute of Emergency Medicine, Zhejiang University</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310009</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mao Zhang, MD</last_name>
      <phone>86-571-87784654</phone>
      <email>z2jzk@zju.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Das SR, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Jordan LC, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, O'Flaherty M, Pandey A, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Spartano NL, Stokes A, Tirschwell DL, Tsao CW, Turakhia MP, VanWagner LB, Wilkins JT, Wong SS, Virani SS; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019 Mar 5;139(10):e56-e528. doi: 10.1161/CIR.0000000000000659. Erratum in: Circulation. 2020 Jan 14;141(2):e33.</citation>
    <PMID>30700139</PMID>
  </reference>
  <reference>
    <citation>Hawkes C, Booth S, Ji C, Brace-McDonnell SJ, Whittington A, Mapstone J, Cooke MW, Deakin CD, Gale CP, Fothergill R, Nolan JP, Rees N, Soar J, Siriwardena AN, Brown TP, Perkins GD; OHCAO collaborators. Epidemiology and outcomes from out-of-hospital cardiac arrests in England. Resuscitation. 2017 Jan;110:133-140. doi: 10.1016/j.resuscitation.2016.10.030. Epub 2016 Nov 17.</citation>
    <PMID>27865775</PMID>
  </reference>
  <reference>
    <citation>Shao F, Li CS, Liang LR, Li D, Ma SK. Outcome of out-of-hospital cardiac arrests in Beijing, China. Resuscitation. 2014 Nov;85(11):1411-7. doi: 10.1016/j.resuscitation.2014.08.008. Epub 2014 Aug 20.</citation>
    <PMID>25151546</PMID>
  </reference>
  <reference>
    <citation>Weisfeldt ML, Becker LB. Resuscitation after cardiac arrest: a 3-phase time-sensitive model. JAMA. 2002 Dec 18;288(23):3035-8.</citation>
    <PMID>12479769</PMID>
  </reference>
  <reference>
    <citation>Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 6: advanced cardiovascular life support: section 1: Introduction to ACLS 2000: overview of recommended changes in ACLS from the guidelines 2000 conference. The American Heart Association in collaboration with the International Liaison Committee on Resuscitation. Circulation. 2000 Aug 22;102(8 Suppl):I86-9.</citation>
    <PMID>10966665</PMID>
  </reference>
  <reference>
    <citation>Laver S, Farrow C, Turner D, Nolan J. Mode of death after admission to an intensive care unit following cardiac arrest. Intensive Care Med. 2004 Nov;30(11):2126-8. Epub 2004 Sep 9.</citation>
    <PMID>15365608</PMID>
  </reference>
  <reference>
    <citation>Singh B, Zhang S, Ching CK, Huang D, Liu YB, Rodriguez DA, Hussin A, Kim YH, Chasnoits AR, Cerkvenik J, Muckala KA, Cheng A. Improving the utilization of implantable cardioverter defibrillators for sudden cardiac arrest prevention (Improve SCA) in developing countries: Clinical characteristics and reasons for implantation refusal. Pacing Clin Electrophysiol. 2018 Dec;41(12):1619-1626. doi: 10.1111/pace.13526. Epub 2018 Oct 31.</citation>
    <PMID>30320410</PMID>
  </reference>
  <reference>
    <citation>Xu F, Zhang Y, Chen Y. Cardiopulmonary Resuscitation Training in China: Current Situation and Future Development. JAMA Cardiol. 2017 May 1;2(5):469-470. doi: 10.1001/jamacardio.2017.0035.</citation>
    <PMID>28297007</PMID>
  </reference>
  <reference>
    <citation>Ringh M, Rosenqvist M, Hollenberg J, Jonsson M, Fredman D, Nordberg P, Järnbert-Pettersson H, Hasselqvist-Ax I, Riva G, Svensson L. Mobile-phone dispatch of laypersons for CPR in out-of-hospital cardiac arrest. N Engl J Med. 2015 Jun 11;372(24):2316-25. doi: 10.1056/NEJMoa1406038.</citation>
    <PMID>26061836</PMID>
  </reference>
  <reference>
    <citation>Kleinman ME, Brennan EE, Goldberger ZD, Swor RA, Terry M, Bobrow BJ, Gazmuri RJ, Travers AH, Rea T. Part 5: Adult Basic Life Support and Cardiopulmonary Resuscitation Quality: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2015 Nov 3;132(18 Suppl 2):S414-35. doi: 10.1161/CIR.0000000000000259. Review.</citation>
    <PMID>26472993</PMID>
  </reference>
  <reference>
    <citation>Brooks SC, Anderson ML, Bruder E, Daya MR, Gaffney A, Otto CW, Singer AJ, Thiagarajan RR, Travers AH. Part 6: Alternative Techniques and Ancillary Devices for Cardiopulmonary Resuscitation: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2015 Nov 3;132(18 Suppl 2):S436-43. doi: 10.1161/CIR.0000000000000260. Review.</citation>
    <PMID>26472994</PMID>
  </reference>
  <reference>
    <citation>Aufderheide TP, Pirrallo RG, Yannopoulos D, Klein JP, von Briesen C, Sparks CW, Deja KA, Kitscha DJ, Provo TA, Lurie KG. Incomplete chest wall decompression: a clinical evaluation of CPR performance by trained laypersons and an assessment of alternative manual chest compression-decompression techniques. Resuscitation. 2006 Dec;71(3):341-51. Epub 2006 Oct 27.</citation>
    <PMID>17070644</PMID>
  </reference>
  <reference>
    <citation>Zhu N, Chen Q, Jiang Z, Liao F, Kou B, Tang H, Zhou M. A meta-analysis of the resuscitative effects of mechanical and manual chest compression in out-of-hospital cardiac arrest patients. Crit Care. 2019 Mar 27;23(1):100. doi: 10.1186/s13054-019-2389-6.</citation>
    <PMID>30917840</PMID>
  </reference>
  <reference>
    <citation>Tang W, Weil MH, Noc M, Sun S, Gazmuri RJ, Bisera J. Augmented efficacy of external CPR by intermittent occlusion of the ascending aorta. Circulation. 1993 Oct;88(4 Pt 1):1916-21.</citation>
    <PMID>8403337</PMID>
  </reference>
  <reference>
    <citation>Gedeborg R, Silander HC, Rubertsson S, Wiklund L. Cerebral ischaemia in experimental cardiopulmonary resuscitation--comparison of epinephrine and aortic occlusion. Resuscitation. 2001 Sep;50(3):319-29.</citation>
    <PMID>11719162</PMID>
  </reference>
  <reference>
    <citation>Tsurukiri J, Akamine I, Sato T, Sakurai M, Okumura E, Moriya M, Yamanaka H, Ohta S. Resuscitative endovascular balloon occlusion of the aorta for uncontrolled haemorrahgic shock as an adjunct to haemostatic procedures in the acute care setting. Scand J Trauma Resusc Emerg Med. 2016 Feb 9;24:13. doi: 10.1186/s13049-016-0205-8. Erratum in: Scand J Trauma Resusc Emerg Med. 2016;24(1):72.</citation>
    <PMID>26861070</PMID>
  </reference>
  <reference>
    <citation>Chaudery M, Clark J, Morrison JJ, Wilson MH, Bew D, Darzi A. Can contrast-enhanced ultrasonography improve Zone III REBOA placement for prehospital care? J Trauma Acute Care Surg. 2016 Jan;80(1):89-94. doi: 10.1097/TA.0000000000000863.</citation>
    <PMID>26683394</PMID>
  </reference>
  <reference>
    <citation>Daley J, Morrison JJ, Sather J, Hile L. The role of resuscitative endovascular balloon occlusion of the aorta (REBOA) as an adjunct to ACLS in non-traumatic cardiac arrest. Am J Emerg Med. 2017 May;35(5):731-736. doi: 10.1016/j.ajem.2017.01.010. Epub 2017 Jan 12. Review.</citation>
    <PMID>28117180</PMID>
  </reference>
  <reference>
    <citation>Brede JR, Lafrenz T, Klepstad P, Skjærseth EA, Nordseth T, Søvik E, Krüger AJ. Feasibility of Pre-Hospital Resuscitative Endovascular Balloon Occlusion of the Aorta in Non-Traumatic Out-of-Hospital Cardiac Arrest. J Am Heart Assoc. 2019 Nov 19;8(22):e014394. doi: 10.1161/JAHA.119.014394. Epub 2019 Nov 11.</citation>
    <PMID>31707942</PMID>
  </reference>
  <reference>
    <citation>Xu J, Shen P, Gao Y, Xia S, Liu S, Li Z, Zhou G, Xu Y, Zhang M. The Effects of the Duration of Aortic Balloon Occlusion on Outcomes of Traumatic Cardiac Arrest in a Porcine Model. Shock. 2019 Sep;52(3):e12-e21. doi: 10.1097/SHK.0000000000001235.</citation>
    <PMID>30052583</PMID>
  </reference>
  <reference>
    <citation>Neumar RW, Nolan JP, Adrie C, Aibiki M, Berg RA, Böttiger BW, Callaway C, Clark RS, Geocadin RG, Jauch EC, Kern KB, Laurent I, Longstreth WT Jr, Merchant RM, Morley P, Morrison LJ, Nadkarni V, Peberdy MA, Rivers EP, Rodriguez-Nunez A, Sellke FW, Spaulding C, Sunde K, Vanden Hoek T. Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council. Circulation. 2008 Dec 2;118(23):2452-83. doi: 10.1161/CIRCULATIONAHA.108.190652. Epub 2008 Oct 23.</citation>
    <PMID>18948368</PMID>
  </reference>
  <reference>
    <citation>Nolan JP, Soar J, Cariou A, Cronberg T, Moulaert VR, Deakin CD, Bottiger BW, Friberg H, Sunde K, Sandroni C. European Resuscitation Council and European Society of Intensive Care Medicine Guidelines for Post-resuscitation Care 2015: Section 5 of the European Resuscitation Council Guidelines for Resuscitation 2015. Resuscitation. 2015 Oct;95:202-22. doi: 10.1016/j.resuscitation.2015.07.018.</citation>
    <PMID>26477702</PMID>
  </reference>
  <reference>
    <citation>Lascarrou JB, Merdji H, Le Gouge A, Colin G, Grillet G, Girardie P, Coupez E, Dequin PF, Cariou A, Boulain T, Brule N, Frat JP, Asfar P, Pichon N, Landais M, Plantefeve G, Quenot JP, Chakarian JC, Sirodot M, Legriel S, Letheulle J, Thevenin D, Desachy A, Delahaye A, Botoc V, Vimeux S, Martino F, Giraudeau B, Reignier J; CRICS-TRIGGERSEP Group. Targeted Temperature Management for Cardiac Arrest with Nonshockable Rhythm. N Engl J Med. 2019 Dec 12;381(24):2327-2337. doi: 10.1056/NEJMoa1906661. Epub 2019 Oct 2.</citation>
    <PMID>31577396</PMID>
  </reference>
  <reference>
    <citation>Schock RB, Janata A, Peacock WF, Deal NS, Kalra S, Sterz F. Time to Cooling Is Associated with Resuscitation Outcomes. Ther Hypothermia Temp Manag. 2016 Dec;6(4):208-217. Epub 2016 Oct 19. Review.</citation>
    <PMID>27906641</PMID>
  </reference>
  <reference>
    <citation>Chenoune M, Lidouren F, Adam C, Pons S, Darbera L, Bruneval P, Ghaleh B, Zini R, Dubois-Randé JL, Carli P, Vivien B, Ricard JD, Berdeaux A, Tissier R. Ultrafast and whole-body cooling with total liquid ventilation induces favorable neurological and cardiac outcomes after cardiac arrest in rabbits. Circulation. 2011 Aug 23;124(8):901-11, 1-7. doi: 10.1161/CIRCULATIONAHA.111.039388. Epub 2011 Aug 1.</citation>
    <PMID>21810660</PMID>
  </reference>
  <reference>
    <citation>Deye N, Cariou A, Girardie P, Pichon N, Megarbane B, Midez P, Tonnelier JM, Boulain T, Outin H, Delahaye A, Cravoisy A, Mercat A, Blanc P, Santré C, Quintard H, Brivet F, Charpentier J, Garrigue D, Francois B, Quenot JP, Vincent F, Gueugniaud PY, Mira JP, Carli P, Vicaut E, Baud FJ; Clinical and Economical Impact of Endovascular Cooling in the Management of Cardiac Arrest (ICEREA) Study Group. Endovascular Versus External Targeted Temperature Management for Patients With Out-of-Hospital Cardiac Arrest: A Randomized, Controlled Study. Circulation. 2015 Jul 21;132(3):182-93. doi: 10.1161/CIRCULATIONAHA.114.012805. Epub 2015 Jun 19. Erratum in: Circulation. 2016 Feb 23;133(8):e418.</citation>
    <PMID>26092673</PMID>
  </reference>
  <reference>
    <citation>Polderman KH, Noc M, Beishuizen A, Biermann H, Girbes AR, Tully GW, Seidman D, Albertsson PA, Holmberg M, Sterz F, Holzer M. Ultrarapid Induction of Hypothermia Using Continuous Automated Peritoneal Lavage With Ice-Cold Fluids: Final Results of the Cooling for Cardiac Arrest or Acute ST-Elevation Myocardial Infarction Trial. Crit Care Med. 2015 Oct;43(10):2191-201. doi: 10.1097/CCM.0000000000001158.</citation>
    <PMID>26196354</PMID>
  </reference>
  <reference>
    <citation>Xu J, Jin X, Chen Q, Wu C, Li Z, Zhou G, Xu Y, Qian A, Li Y, Zhang M. Faster Hypothermia Induced by Esophageal Cooling Improves Early Markers of Cardiac and Neurological Injury After Cardiac Arrest in Swine. J Am Heart Assoc. 2018 Nov 6;7(21):e010283. doi: 10.1161/JAHA.118.010283.</citation>
    <PMID>30608213</PMID>
  </reference>
  <reference>
    <citation>Xu J, Chen Q, Jin X, Wu C, Li Z, Zhou G, Xu Y, Qian A, Li Y, Zhang M. Early Initiation of Continuous Renal Replacement Therapy Induces Fast Hypothermia and Improves Post-Cardiac Arrest Syndrome in a Porcine Model. Shock. 2019 Oct;52(4):456-467. doi: 10.1097/SHK.0000000000001276.</citation>
    <PMID>30335673</PMID>
  </reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 20, 2021</study_first_submitted>
  <study_first_submitted_qc>June 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 8, 2021</study_first_posted>
  <last_update_submitted>June 28, 2021</last_update_submitted>
  <last_update_submitted_qc>June 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>5G</keyword>
  <keyword>Aortic Balloon Occlusion Catheter</keyword>
  <keyword>Esophageal cooling device</keyword>
  <keyword>Cardiopulmonary resuscitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Arrest</mesh_term>
    <mesh_term>Emergencies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

